Compagnie Lombard Odier SCmA’s Exact Sciences EXAS Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$20K	–	649
2022 Q2	$20K	Hold	500	–	–	﹤0.01%	511
2022 Q1	$35K	Sell	500 -500	-50%	-$36.5K	﹤0.01%	482
2021 Q4	$78K	Hold	1,000	–	–	﹤0.01%	465
2021 Q3	$95K	Sell	1,000 -2,450	-71%	-$259K	﹤0.01%	435
2021 Q2	$429K	Sell	3,450 -143,610	-98%	-$17.1M	0.01%	250
2021 Q1	$19.4M	Buy	147,060 +144,310	+5,248%	+$19.8M	0.43%	50
2020 Q4	$365K	Buy	2,750 +300	+12%	+$36.3K	0.01%	262
2020 Q3	$250K	Hold	2,450	–	–	0.01%	255
2020 Q2	$213K	Hold	2,450	–	–	0.01%	260
2020 Q1	$142K	Hold	2,450	–	–	0.01%	270
2019 Q4	$227K	Buy	+2,450	New	+$215K	0.01%	242

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Compagnie Lombard Odier SCmA's EXAS Position: Q3 2022 in Review

Compagnie Lombard Odier SCmA sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 500 shares — an estimated $20K sold.

Compagnie Lombard Odier SCmA first reported a position in EXAS in Q4 2019 and held it in 11 quarters. The position peaked at $19.4M in Q1 2021. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

Compagnie Lombard Odier SCmA reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 500 Exact Sciences shares in Q3 2022, an estimated $20K.
Compagnie Lombard Odier SCmA first reported a position in Exact Sciences in Q4 2019 and held it in 11 quarters.
Compagnie Lombard Odier SCmA's Exact Sciences position peaked at $19.4M in Q1 2021.
480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2022, filed 9 Nov 2022.